Torthaí cuardaigh - Thomas A. DiPetrillo
- 1 - 15 toradh as 15 á dtaispeáint
-
1
Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma de réir Amy Law, Daniel D. Karp, Thomas A. DiPetrillo, Benedict T. Daly
Foilsithe / Cruthaithe 2001Artigo -
2
Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974–2011 de réir Esther Yee Tak Yu, P.P. Koffer, Thomas A. DiPetrillo, Timothy J. Kinsella
Foilsithe / Cruthaithe 2016Artigo -
3
Dexamethasone decreases the amounts of type I procollagen mRNAs in vivo and in fibroblast cell cultures. de réir Kenneth Sterling, Matthew J. Harris, Jan Mitchell, Thomas A. DiPetrillo, G L Delaney, Kenneth R. Cutroneo
Foilsithe / Cruthaithe 1983Artigo -
4
Limited resection for non–small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds de réir Winnie Lee, Benedict D.T. Daly, Thomas A. DiPetrillo, Donna M. Morelli, Andrew C. Neuschatz, Jody Morr, Mark J. Rivard
Foilsithe / Cruthaithe 2003Artigo -
5
Percutaneous radiofrequency ablation of painful osseous metastases de réir Damian E. Dupuy, Dawei Liu, Donna Hartfeil, Lucy Hanna, Jeffrey D. Blume, Kamran Ahrar, Robert Lopez‐Ben, Howard Safran, Thomas A. DiPetrillo
Foilsithe / Cruthaithe 2009Artigo -
6
RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma de réir Prakash Chinnaiyan, Minhee Won, Patrick Y. Wen, Amyn M. Rojiani, Merideth M Wendland, Thomas A. DiPetrillo, Benjamin W. Corn, Minesh P. Mehta
Foilsithe / Cruthaithe 2013Artigo -
7
ErbB2 Degradation Mediated by the Co-chaperone Protein CHIP de réir Pengcheng Zhou, Norvin D. Fernandes, Ingrid Dodge, Alagarsamy Lakku Reddi, Navin Rao, Howard Safran, Thomas A. DiPetrillo, David E. Wazer, Vimla Band, Hamid Band
Foilsithe / Cruthaithe 2003Artigo -
8
Chemoradiotherapy and Gefitinib in Stage III Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor and KRAS Mutation Analysis: Cancer and Leukemia Group B (CALEB) 30106,... de réir Neal Ready, Pasi A. Jänne, Jeffrey A. Bogart, Thomas A. DiPetrillo, Jennifer Garst, Stephen L. Graziano, Lin Gu, Xiaofei Wang, Mark R. Green, Everett E. Vokes
Foilsithe / Cruthaithe 2010Artigo -
9
MammoSite and interstitial brachytherapy for accelerated partial breast irradiation de réir Neenad M. Shah, Todd Tenenholz, Douglas W. Arthur, Thomas A. DiPetrillo, Bruce A. Bornstein, Gene A. Cardarelli, Zhen Zheng, Mark J. Rivard, Seth Kaufman, David E. Wazer
Foilsithe / Cruthaithe 2004Artigo -
10
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032) de réir Michael S. Kent, Sumithra J. Mandrekar, Rodney J. Landreneau, Francis Nichols, Nathan R. Foster, Thomas A. DiPetrillo, Bryan F. Meyers, Dwight E. Heron, David R. Jones, Angelina D. Tan, Sandra L. Starnes, Joe B. Putnam, Hiran C. Fernando
Foilsithe / Cruthaithe 2016Artigo -
11
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: Results from the ACOSOG Z4032 (Alliance) multicenter randomized trial de réir Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Francis C. Nichols, Thomas A. DiPetrillo, Bryan F. Meyers, Dwight E. Heron, Shauna L. Hillman, David R. Jones, Sandra L. Starnes, Angelina D. Tan, Benedict D.T. Daly, Joe B. Putnam
Foilsithe / Cruthaithe 2014Artigo -
12
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non–small cell lung cancer: Results from a multicenter phase III study de réir Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Shauna L. Hillman, Francis C. Nichols, Bryan F. Meyers, Thomas A. DiPetrillo, Dwight E. Heron, David R. Jones, Benedict D.T. Daly, Sandra L. Starnes, Angelina D. Tan, Joe B. Putnam
Foilsithe / Cruthaithe 2011Artigo -
13
Impact of Brachytherapy on Local Recurrence Rates After Sublobar Resection: Results From ACOSOG Z4032 (Alliance), a Phase III Randomized Trial for High-Risk Operable Non–Small-Cell... de réir Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Francis C. Nichols, Shauna L. Hillman, Dwight E. Heron, Bryan F. Meyers, Thomas A. DiPetrillo, David R. Jones, Sandra L. Starnes, Angelina D. Tan, Benedict D.T. Daly, Joe B. Putnam
Foilsithe / Cruthaithe 2014Artigo -
14
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head de réir Ross A. Abrams, Kathryn Winter, Howard Safran, Karyn A. Goodman, William F. Regine, Adam C. Berger, Michael T. Gillin, Philip A. Philip, Andrew M. Lowy, Abraham J. Wu, Thomas A. DiPetrillo, Benjamin W. Corn, Samantha A. Seaward, Michael G. Haddock, Suisui Song, Yixing Jiang, Barbara J. Fisher, Alan W. Katz, Sharmila Mehta, Christopher G. Willett, Christopher H. Crane
Foilsithe / Cruthaithe 2020Artigo -
15
TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury de réir Jillian Strandberg, Anna D. Louie, Seulki Lee, Marina Hahn, Praveen Srinivasan, Andrew George, Arielle De La Cruz, Leiqing Zhang, Liz Hernandez Borrero, Kelsey E. Huntington, Payton De La Cruz, Attila A. Seyhan, P.P. Koffer, David E. Wazer, Thomas A. DiPetrillo, Stephanie L. Graff, Christopher G. Azzoli, Sharon Rounds, Andres J. Klein–Szanto, Fabio Tavora, Evgeny Yakirevich, Abbas E. Abbas, Lanlan Zhou, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2025Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Surgery
Oncology
Radiation therapy
Lung cancer
Brachytherapy
Cancer
Radiology
Biology
Chemotherapy
Confidence interval
Hazard ratio
Lung
Randomized controlled trial
Resection
Adverse effect
Biochemistry
Cell biology
Chemistry
Chemoradiotherapy
Clinical endpoint
Disease
Epidermal growth factor receptor
Erlotinib
Gastroenterology
Nuclear medicine
Resection margin
Toxicity
Ablation